Lincoln Pharmaceuticals Board Meeting on Aug 13, 2026

Lincoln Pharmaceuticals Ltd has announced that its Board of Directors will convene on August 13, 2026, at the company's registered office. The primary agenda items include the consideration and approval of the un-audited financial results (standalone and consolidated) for the quarter ended June 30, 2026. Additionally, the board may discuss any other business with the Chairman's permission. In compliance with SEBI regulations, the trading window for the company's securities has been closed from July 1, 2026, and will reopen 48 hours after the financial results are made public. The company secretary and compliance officer, Trusha Shah, has formally intimated this to BSE.